CANF logo

Can-Fite BioPharma (CANF) Depreciation And Amortization

Annual D&A

$15.00 K
+$1000.00+7.14%

December 31, 2023


Summary


Performance

CANF Depreciation And Amortization Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

Related metrics

Quarterly D&A

N/A

June 30, 2024


Summary


Performance

CANF Quarterly D&A Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

Earnings dates

Related metrics

TTM D&A

N/A

June 30, 2024


Summary


Performance

CANF TTM D&A Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

Earnings dates

Related metrics

CANF Depreciation And Amortization Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+7.1%--
3 y3 years+25.0%--
5 y5 years+7.1%--

CANF Depreciation And Amortization Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-yearat high+7.1%
5 y5-yearat high+25.0%
alltimeall time-80.9%+25.0%

Can-Fite BioPharma Depreciation And Amortization History

DateAnnualQuarterlyTTM
Dec 2023
$15.00 K(+7.1%)
-
-
Dec 2022
$14.00 K(0.0%)
-
-
Dec 2021
$14.00 K(+16.7%)
-
-
Dec 2020
$12.00 K(-14.3%)
-
-
Dec 2019
$14.00 K(0.0%)
-
-
Dec 2018
$14.00 K(-26.3%)
-
-
Dec 2017
$19.00 K(+5.6%)
-
-
Dec 2016
$18.00 K(+9.8%)
-
-
Dec 2015
$16.40 K(+35.5%)
-
-
Dec 2014
$12.10 K(-27.5%)
-
-
Dec 2013
$16.70 K
$4300.00(-12.2%)
$16.60 K(-5.1%)
Sep 2013
-
$4900.00(+36.1%)
$17.50 K(-1.7%)
DateAnnualQuarterlyTTM
Jun 2013
-
$3600.00(-5.3%)
$17.80 K(+439.4%)
Mar 2013
-
$3800.00(-26.9%)
$3300.00(-85.6%)
Dec 2012
$23.00 K(-59.9%)
-
-
Dec 2012
-
$5200.00(0.0%)
$22.90 K(-21.8%)
Sep 2012
-
$5200.00(-147.7%)
$29.30 K(-14.1%)
Jun 2012
-
-$10.90 K(-146.6%)
$34.10 K(-44.6%)
Mar 2012
-
$23.40 K(+101.7%)
$61.50 K(+7.5%)
Dec 2011
$57.30 K(-27.1%)
-
-
Dec 2011
-
$11.60 K(+16.0%)
$57.20 K(+25.4%)
Sep 2011
-
$10.00 K(-39.4%)
$45.60 K(+28.1%)
Jun 2011
-
$16.50 K(-13.6%)
$35.60 K(+86.4%)
Mar 2011
-
$19.10 K
$19.10 K
Dec 2010
$78.60 K
-
-

FAQ

  • What is Can-Fite BioPharma annual depreciation & amortization?
  • What is the all time high annual D&A for Can-Fite BioPharma?
  • What is Can-Fite BioPharma annual D&A year-on-year change?
  • What is the all time high quarterly D&A for Can-Fite BioPharma?
  • What is the all time high TTM D&A for Can-Fite BioPharma?

What is Can-Fite BioPharma annual depreciation & amortization?

The current annual D&A of CANF is $15.00 K

What is the all time high annual D&A for Can-Fite BioPharma?

Can-Fite BioPharma all-time high annual depreciation & amortization is $78.60 K

What is Can-Fite BioPharma annual D&A year-on-year change?

Over the past year, CANF annual depreciation & amortization has changed by +$1000.00 (+7.14%)

What is the all time high quarterly D&A for Can-Fite BioPharma?

Can-Fite BioPharma all-time high quarterly depreciation & amortization is $23.40 K

What is the all time high TTM D&A for Can-Fite BioPharma?

Can-Fite BioPharma all-time high TTM depreciation & amortization is $61.50 K